Next Article in Journal
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information
Previous Article in Journal
Primary Sequence and Three-Dimensional Structural Comparison between Malanin and Ricin, a Type II Ribosome-Inactivating Protein
Previous Article in Special Issue
Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade after Approval: A Single-Blind Study to Evaluate the Reduction in Pain in OnabotulinumtoxinA Detrusor Injection Using Different Injection Needles
 
 
Article

Article Versions Notes

Toxins 2024, 16(10), 441; https://doi.org/10.3390/toxins16100441 (registering DOI)
Action Date Notes Link
article xml file uploaded 14 October 2024 11:44 CEST Original file -
article xml uploaded. 14 October 2024 11:44 CEST Update -
article pdf uploaded. 14 October 2024 11:44 CEST Version of Record https://www.mdpi.com/2072-6651/16/10/441/pdf-vor
article supplementary file uploaded. 14 October 2024 11:44 CEST - https://www.mdpi.com/2072-6651/16/10/441#supplementary
article html file updated 14 October 2024 11:46 CEST Original file -
article xml file uploaded 15 October 2024 08:31 CEST Update -
article xml uploaded. 15 October 2024 08:31 CEST Update https://www.mdpi.com/2072-6651/16/10/441/xml
article pdf uploaded. 15 October 2024 08:31 CEST Updated version of record https://www.mdpi.com/2072-6651/16/10/441/pdf
article html file updated 15 October 2024 08:33 CEST Update https://www.mdpi.com/2072-6651/16/10/441/html
Back to TopTop